SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-21-016099
Filing Date
2021-08-06
Accepted
2021-08-06 16:37:42
Documents
20

Document Format Files

Seq Description Document Type Size
1 424B3 nautilus424b3.htm 424B3 2900962
2 business10aa.jpg GRAPHIC 45011
3 business11aa.jpg GRAPHIC 97071
4 business12aa.jpg GRAPHIC 92686
5 business13aa.jpg GRAPHIC 19977
6 business14aa.jpg GRAPHIC 77168
7 business15aa.jpg GRAPHIC 109911
8 business16aa.jpg GRAPHIC 39343
9 business17aa.jpg GRAPHIC 33046
10 business18aa.jpg GRAPHIC 176571
11 business1aa.jpg GRAPHIC 131188
12 business2aa.jpg GRAPHIC 110086
13 business3aa.jpg GRAPHIC 117780
14 business4aa.jpg GRAPHIC 88581
15 business5aa.jpg GRAPHIC 67439
16 business6aa.jpg GRAPHIC 127790
17 business7aa.jpg GRAPHIC 196912
18 business8aa.jpg GRAPHIC 144608
19 business9aa.jpg GRAPHIC 24808
20 nautiluslogoa.jpg GRAPHIC 106309
  Complete submission text file 0001628280-21-016099.txt   5390288
Mailing Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109
Business Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258100 | Film No.: 211153440
SIC: 6770 Blank Checks